$KLRA
Kailera Therapeutics, Inc. Common Stock
XNAS
Why is KLRA up today? It is at $18.36 (+1.05%), and our scanner flagged it 21 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment KLRA spikes, and full due diligence on KLRA — key stats, earnings, dilution and insider activity. Free.
Get free $KLRA alerts the moment volume spikes
Our scanner flagged $KLRA 21 times in the last 30 days. Create a free account to track $KLRA, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $18.36
- Change today
- +1.05%
- Previous close
- $18.17
- 52-week range
- $16.39 – $28.23
- Market cap
- $2.35B
- Institutional own.
- 0.51%
- Total held
- 0.51%
- Tradeable float
- 128.9M 99% of shares · after 1% institutions
- Short interest
- 6.4M ▲ +26% vs prior · as of 2026-07-15
- Short % of float
- 5.0%
- Days to cover
- 9.3d
- Avg daily volume
- 840K
- Next earnings
- Aug 25 · in 19d
- Exchange
- XNAS
- 5m
- 0.7x
- 15m
- 0.6x
- 1h
- 0.3x
- 1D
- 0.0x
Get free KLRA + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $KLRA up today?
Here is the latest on KLRA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for KLRA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystQuarterly report (10-Q), from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
5 open-market buys0 buys, 0 sells last 3 months (11/0 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Renaud Ronald C Jr Officer | Other | 38K 0.03% of company | n/a | 38K | $200K at $5.25 | Jun 9, 26 |
Kaplan Andrew T. Director | Acquired (grant/award) | +17.86M 13.8% of company | n/a | 17.86M | n/a | Apr 20, 26 |
Kaplan Andrew T. Director | Bought (open market) | +8.40M 6.5% of company | added 47% | 26.26M | $134.4M at $16.00 | Apr 20, 26 |
Bain Capital Life Sciences Investors, Llc Beneficial Owner (10%) | Acquired (grant/award) | +21.02M 16.2% of company | n/a | 21.02M | n/a | Apr 20, 26 |
Bain Capital Life Sciences Investors, Llc Beneficial Owner (10%) | Bought (open market) | +1.56M 1.2% of company | added 7.4% | 22.58M | $25.0M at $16.00 | Apr 20, 26 |
Koppel Adam Director | Acquired (grant/award) | +21.02M 16.2% of company | n/a | 21.02M | n/a | Apr 20, 26 |
Koppel Adam Director | Bought (open market) | +1.56M 1.2% of company | added 7.4% | 22.58M | $25.0M at $16.00 | Apr 20, 26 |
Bain Capital Investors Llc Beneficial Owner (10%) | Acquired (grant/award) | +17.86M 13.8% of company | n/a | 17.86M | n/a | Apr 20, 26 |
Bain Capital Investors Llc Beneficial Owner (10%) | Bought (open market) | +8.40M 6.5% of company | added 47% | 26.26M | $134.4M at $16.00 | Apr 20, 26 |
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Beneficial Owner (10%) | Acquired (grant/award) | +11.51M 8.9% of company | n/a | 9.48M | n/a | Apr 20, 26 |
Rtw Investments, Lp Beneficial Owner (10%) | Acquired (grant/award) | +10.28M 7.9% of company | n/a | 10.28M | n/a | Apr 20, 26 |
Rtw Investments, Lp Beneficial Owner (10%) | Bought (open market) | +500K 0.4% of company | added 4.9% | 10.78M | $8.0M at $16.00 | Apr 20, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $KLRA runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- At-the-market (ATM) program — sells new shares into the market gradually over time · About $225M in size · Priced at $16.00/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$KLRA Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$KLRA Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
KLRA stock FAQ
Why is $KLRA up today?
Here is the latest on KLRA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for KLRA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the KLRA stock price today?
KLRA last traded at $18.36, up 1.05% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
When does KLRA report earnings?
Kailera Therapeutics, Inc. Common Stock (KLRA) is next expected to report earnings on Tuesday, August 25, 2026, about 19 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Where can I see live KLRA alerts?
The KLRA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged KLRA 21 times in the last 30 days.
What exchange is KLRA on?
KLRA (Kailera Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $2.35B.
Is KLRA good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge KLRA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.